Fitness trackers can be valuable tools for assessing the quality of life and daily functioning of cancer patients during treatment, a new study has found. The trackers, also known as wearable activity monitors, include commercial ...
Jul 24, 2018
0
25
New long-term use of opioids to quell pain after lung cancer surgery is linked to a 40% heightened risk of death from any cause within the next 2 years, finds research published online in the journal Regional Anesthesia & ...
Sep 12, 2022
0
87
(HealthDay)—The U.S. Food and Drug Administration has given its blessing to the first immunotherapy regimen for breast cancer.
Mar 12, 2019
0
54
Known as two of the most lethal cancers, ovarian and pancreatic cancer are often called silent killers since they rarely have early symptoms. As a result, they frequently go undetected until they're too late to effectively ...
Jul 22, 2019
0
6
University Hospitals (UH) Seidman Cancer Center treated its first patient in a new clinical trial to validate the groundbreaking effects of the poliovirus on glioblastoma (GBM), a deadly Grade IV cancer of the brain.
Jan 24, 2020
0
5
Researchers at the University of Oxford are now closer to finding the cell of origin of ovarian cancer, and their ultimate aim of developing a much needed screening tool for ovarian cancer.
Feb 10, 2020
0
1410
Comprehensive profiling of tumor samples taken from patients with osteosarcoma shows that multiple factors contribute to the traditionally poor responses observed from treatment with immune checkpoint inhibitors, according ...
Feb 21, 2020
0
183
In the ongoing quest to discover which constituents of the immune system provide highly specified protection, scientists have found that a component of the innate immune system is endowed with the capability of guarding the ...
A new study led by researchers from the Royal Women's Hospital shows that young adults born extremely premature are susceptible to high blood pressure, putting them at higher risk of heart disease in later life.
Feb 10, 2020
0
2
The combination of dasatinib, blinatumomab, and prednisone can be effective in treating older patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) who are not good candidates for intensive ...
Dec 13, 2021
0
2
